A Study to Investigate the Genetic Variation of Dopamine Pathway in Patients With Chronic Pain

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

110 participants

Study Classification

INTERVENTIONAL

Study Start Date

2017-02-08

Study Completion Date

2017-10-05

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Patients having completed former trials T1001-01 or T1001-02 will undergo one blood sampling for genotyping purposes. In addition they will compete the personality questionnaires they had completed in the former trial.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

A Proof of Concept Study to Investigate the Effect of a New Treatment in Patient With Chronic Pain

NCT02459197

Peripheral Neuropathies Osteoarthritis

COMPLETED NA

A Study to Investigate the Effects of a New Treatment in Patients With Chronic Pain

NCT02301169

Peripheral Neuropathies

COMPLETED NA

A Trial in Painful Diabetic Peripheral Neuropathy With GRT3983Y

NCT01056315

Painful Diabetic Neuropathy

TERMINATED PHASE2

A Study of Single Dose Pain Therapy in Patients With Painful Diabetic Neuropathy (0000-115)

NCT00837941

Painful Diabetic Neuropathy

WITHDRAWN PHASE2

Effect of L-dopa In Subacute Back Pain Population

NCT01951105

Sub-acute Back Pain

COMPLETED PHASE4

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Peripheral Neuropathy Osteoarthritis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

BASIC_SCIENCE

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Unique study arm

Group Type OTHER

Blood sampling for genotyping

Intervention Type GENETIC

Venous punction of maximum 10 millilitres

Personality Questionnaires completion

Intervention Type OTHER

Completion of the following questionnaires: Multidimensional Personality Questionnaire (MPSQ), Interpersonal Reactivity Index (IRI) and Behavioral inhibition system/ Behavioral activation systems (BISBAS) questionnaires

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Blood sampling for genotyping

Venous punction of maximum 10 millilitres

Intervention Type GENETIC

Personality Questionnaires completion

Completion of the following questionnaires: Multidimensional Personality Questionnaire (MPSQ), Interpersonal Reactivity Index (IRI) and Behavioral inhibition system/ Behavioral activation systems (BISBAS) questionnaires

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* have completed T1001-01 or T1001-02 study (Visit 5 completed)
* are men or women of at least 18 years of age
* have given written informed consent approved by the relevant Ethics Committee governing the study sites